India’s retail investing boom has brought millions of first-time investors into mutual funds, stocks and insurance products, but according to Nithin Kamath, investors continue to repeat the same ...
Zerodha Co-founder Nithin Kamath has cautioned that the rapid rise in margin trading facility (MTF) exposure across India’s brokerage industry could emerge as a serious threat to the broader stock ...
Dr. Reddy’s Laboratories has launched in India oral semaglutide biosimilar in tablet form. The product will be available under Obeda brand, the same name under which the Hyderabad-based generic ...
The Indian government’s decision to raise import duties on gold and silver to 15% triggered a sharp reaction in bullion markets, but according to Zerodha co-founder Nithin Kamath, what stood out most ...
A licensed attorney with nearly a decade of experience in content production, Valerie Catalano knows how to help readers digest complicated information about the law ...
Sameera Reddy made her Telugu debut with Narasimhudu in 2004. She was paired opposite Jr. NTR in the film. In the Hindi film industry, she was still new back then. Her team and the people around her ...
Dr Reddy’s and Nestlé Health Science, a joint venture between Dr. Reddy’s Laboratories and Nestle India, launched Celevida GLP Plus in the domestic market. It is a specialised product to support ...
Dr Reddy shares: Shares of pharma major Dr Reddy's Laboratories swung between gains and losses in morning deals on the BSE on Wednesday, 13 May, a day after reporting a 86% year-on-year (YoY) drop in ...
Pharma major Dr Reddy’s Laboratories is likely to post a dip in its consolidated net profit at about ₹1,040 crore in the fourth quarter ended March 31, 2026 compared to ₹1,587 crore in the ...
The high-end fashion event, Met Gala, is an invite-only event. This year, Reddy attended the event in collaboration with designer Manish Malhotra and stylish Mariel Haenn. This is Reddy's third ...
Sequentially, or on a quarter-on-quarter (QoQ) basis, Dr Reddy's profit fell nearly 82% from ₹1,209.8 crore in Q3FY26. The sharp decline in profit was impacted by a shelf stock adjustment related to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results